UPJOHN CO. v. MOVA PHARMACEUTICAL CORP.

No. 99-1092.

225 F.3d 1306 (2000)

The UPJOHN COMPANY, Plaintiff-Appellant, v. MOVA PHARMACEUTICAL CORP., Defendant-Appellee.

United States Court of Appeals, Federal Circuit.

September 11, 2000.


Attorney(s) appearing for the Case

Gerald Sobel, Kaye, Scholer, Fierman, Hays & Handler, LLP, New York, New York, argued for plaintiff-appellant. With him on the brief were Steven J. Glassman and Steven D. Roth.

Ronald L. Grudziecki, Burns, Doane, Swecker & Mathis, L.L.P., Alexandria, Virginia, argued for defendant-appellee. With him on the brief were Matthew P. Blischak, Susan M. Dadio, and Alan L. Whitehurst, of Alexandria, Virginia, and Allen R. Baum, of Durham, North Carolina.

Before NEWMAN, Circuit Judge, SKELTON and ARCHER, Senior Circuit Judges.


PAULINE NEWMAN, Circuit Judge.

In response to the filing by MOVA Pharmaceutical Corporation of an Abbreviated New Drug Application (ANDA) for a bioequivalent form of Upjohn's formulation of the anti-diabetic drug glyburide, in accordance with 21 U.S.C. § 355(j) the Upjohn Company filed suit charging MOVA with infringement of United States Patent No. 4,916,163 (the '163 patent). The United States District Court for the District of Puerto Rico entered judgment...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases